2026 Interim Report
Filed with HKEX · Stock code 1609 · · 53 pages · English
Summary by 6ix AI
The report highlights the company's revenue growth and expansion in both domestic and international markets, emphasizing advancements in their technology platforms and product offerings. It also discusses the company's R&D investments and the progress of various product pipelines, showcasing their commitment to innovation in sports medicine solutions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Star Sports Medicine Co., Ltd on 6ix
Earlier from Star Sports Medicine
Later from Star Sports Medicine
- Circular of the 2026 second extraordinary general meeting
- Notice of extraordinary shareholders' meeting
- Proxy form for the 2026 second extraordinary shareholders' meeting to be held on Thursday, October 22, 2026
- An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
- Next Day Disclosure Return
Follow Star Sports Medicine into a list and get an email when it puts out news.
Follow Star Sports Medicine